Skip to main content

Peer Review reports

From: Immune checkpoint inhibitor plus chemotherapy as first-line treatment for non-small cell lung cancer with malignant pleural effusion: a retrospective multicenter study

Original Submission
22 Dec 2023 Submitted Original manuscript
11 Jan 2024 Reviewed Reviewer Report
29 Jan 2024 Reviewed Reviewer Report
2 Mar 2024 Author responded Author comments - Panwen Tian
18 Mar 2024 Reviewed Reviewer Report
19 Mar 2024 Reviewed Reviewer Report
Resubmission - Version 2
2 Mar 2024 Submitted Manuscript version 2
Publishing
22 Mar 2024 Editorially accepted
28 Mar 2024 Article published 10.1186/s12885-024-12173-1

You can find further information about peer review here.

Back to article page